Insider Trading & Ownership - Artiva Biotherapeutics Inc. (ARTV)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Artiva Biotherapeutics Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-07-22
Purchase
2024-07-24
4:27 pm
Artiva Biotherapeutics Inc.ARTVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
8,333,333$12$99,999,9961,288,519
(Indirect)
View
2024-07-22
Purchase
2024-07-24
4:15 pm
Artiva Biotherapeutics Inc.ARTV5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
833,333$12$9,999,9961,643,741
(Indirect)
View
2024-07-22
Purchase
2024-07-22
8:26 pm
Artiva Biotherapeutics Inc.ARTVvenBio Global Strategic Fund III L.P.
VENBIO GLOBAL STRATEGIC GP III L.P.
VENBIO GLOBAL STRATEGIC GP III LTD
Adelman Robert J
GOODMAN COREY S
10% Owner
416,666$12$4,999,9922,398,324
(Direct)
View
2024-07-22
Purchase
2024-07-22
8:25 pm
Artiva Biotherapeutics Inc.ARTVGC Corp.
GC Cell Corp
10% Owner
2,083,332$12$24,999,9845,117,845
(Indirect
Direct)
View
2024-07-22
Purchase
2024-07-22
8:22 pm
Artiva Biotherapeutics Inc.ARTVHuh Yong-Jun
Director
2,083,332$12$24,999,9841,810,945
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-21
Option Award
2024-10-22
8:18 pm
N/A
2034-10-20
Artiva Biotherapeutics Inc.ARTVMOORE ALISON
Director
27,500$027,500
(Direct)
View
2024-09-12
Option Award
2024-09-13
4:15 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVRaymon Heather
SVP, Research and Development
10,000$010,000
(Direct)
View
2024-09-12
Option Award
2024-09-13
4:15 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVGraef Thorsten
Chief Medical Officer
20,000$020,000
(Direct)
View
2024-09-12
Option Award
2024-09-13
4:15 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVHoran Christopher
Chief Tech Operations Officer
25,000$025,000
(Direct)
View
2024-09-12
Option Award
2024-09-13
4:15 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVKrishnamohan Neha
Chief Financial Officer
50,000$050,000
(Direct)
View
2024-09-12
Option Award
2024-09-13
4:15 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVBush Jennifer
COO, CLO, Secy, Compliance Off
50,000$072,799
(Direct)
View
2024-07-22
Conversion
2024-07-24
4:27 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
2,048,244$01,288,519
(Indirect)
View
2024-07-22
Other
2024-07-24
4:27 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
RA Capital Nexus Fund III L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
461,687$10.21,288,519
(Indirect)
View
2024-07-22
Conversion
2024-07-24
4:15 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTV5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
2,116,568$01,643,741
(Indirect)
View
2024-07-22
Other
2024-07-24
4:15 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTV5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
461,687$10.21,643,741
(Indirect)
View
2024-07-22
Conversion
2024-07-22
8:28 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVWellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
145,089$0243,127
(Direct)
View
2024-07-22
Other
2024-07-22
8:28 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVWellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
49,019$10.2243,127
(Direct)
View
2024-07-22
Conversion
2024-07-22
8:26 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVvenBio Global Strategic Fund III L.P.
VENBIO GLOBAL STRATEGIC GP III L.P.
VENBIO GLOBAL STRATEGIC GP III LTD
Adelman Robert J
GOODMAN COREY S
10% Owner
1,058,284$02,398,324
(Direct)
View
2024-07-22
Other
2024-07-22
8:26 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVvenBio Global Strategic Fund III L.P.
VENBIO GLOBAL STRATEGIC GP III L.P.
VENBIO GLOBAL STRATEGIC GP III LTD
Adelman Robert J
GOODMAN COREY S
10% Owner
461,687$02,398,324
(Direct)
View
2024-07-22
Conversion
2024-07-22
8:25 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVGC Corp.
GC Cell Corp
10% Owner
1,352,252$05,117,845
(Direct)
View
2024-07-22
Other
2024-07-22
8:25 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVGC Corp.
GC Cell Corp
10% Owner
550,433$10.25,117,845
(Direct)
View
2024-07-22
Conversion
2024-07-22
8:22 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVHuh Yong-Jun
Director
1,352,252$01,810,945
(Indirect)
View
2024-07-22
Other
2024-07-22
8:22 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVHuh Yong-Jun
Director
550,433$10.21,810,945
(Indirect)
View
2024-07-18
Option Award
2024-07-22
8:18 pm
N/A
2034-07-17
Artiva Biotherapeutics Inc.ARTVAslan Fred
President and CEO
572,716$0572,716
(Direct)
View

Ownership
2024-07-18
8:14 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVvenBio Global Strategic Fund III L.P.
VENBIO GLOBAL STRATEGIC GP III L.P.
VENBIO GLOBAL STRATEGIC GP III LTD
Adelman Robert J
GOODMAN COREY S
10% Owner
0$01,058,284
(Direct)
View

Ownership
2024-07-18
8:08 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVRA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
RA Capital Nexus Fund L.P.
Kolchinsky Peter
Shah Rajeev M.
Director
10% Owner
0$01,058,282
(Indirect)
View

Ownership
2024-07-18
8:06 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTV5AM Partners VI LLC
5AM Ventures VI L.P.
PARMAR KUSH
Schwab Andrew J.
10% Owner
0$01,058,284
(Indirect)
View

Ownership
2024-07-18
8:06 pm
2024-05-01
2034-01-23
Artiva Biotherapeutics Inc.ARTVMiralles Gines Diego
Director
0$025,990
(Direct)
View

Ownership
2024-07-18
8:06 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVWellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
0$0145,089
(Direct)
View

Ownership
2024-07-18
8:05 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVGC Corp.
GC Cell Corp
10% Owner
0$01,933,647
(Direct)
View

Ownership
2024-07-18
8:04 pm
N/A
2033-04-02
Artiva Biotherapeutics Inc.ARTVHOUGEN ELIZABETH L
Director
0$017,098
(Direct)
View

Ownership
2024-07-18
8:02 pm
N/A
2030-11-02
Artiva Biotherapeutics Inc.ARTVRaymon Heather
SVP, Research and Development
0$067,255
(Direct)
View

Ownership
2024-07-18
8:02 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVHuh Yong-Jun
Director
0$01,933,647
(Indirect)
View

Ownership
2024-07-18
8:02 pm
N/A
2033-04-02
Artiva Biotherapeutics Inc.ARTVBessen Laura
Director
0$017,098
(Direct)
View

Ownership
2024-07-18
8:01 pm
N/A
2033-04-02
Artiva Biotherapeutics Inc.ARTVGraef Thorsten
Chief Medical Officer
0$0110,578
(Direct)
View

Ownership
2024-07-18
8:01 pm
N/A
2034-05-01
Artiva Biotherapeutics Inc.ARTVKrishnamohan Neha
Chief Financial Officer
0$0102,599
(Direct)
View

Ownership
2024-07-18
8:01 pm
N/A
2033-04-02
Artiva Biotherapeutics Inc.ARTVHoran Christopher
Chief Tech Operations Officer
0$0107,157
(Direct)
View

Ownership
2024-07-18
8:00 pm
N/A
N/A
Artiva Biotherapeutics Inc.ARTVBush Jennifer
COO, CLO, Secy, Compliance Off
0$0107,678
(Direct)
View

Ownership
2024-07-18
8:00 pm
N/A
2033-04-02
Artiva Biotherapeutics Inc.ARTVAslan Fred
President and CEO
0$0549,808
(Direct)
View